Drug Pipeline

Testosterone Enanthate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04363164 Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression Castration Resistant Metastatic Prostate Cancer Recruiting
NCT03522064 Bipolar Androgen Therapy + Carboplatin in mCRPC Castration-resistant Prostate Cancer Recruiting
NCT06594926 Working Out M0 Bipolar Androgen Therapy Prostate Cancer Recruiting
Not specified
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Testosterone Enanthate Trials
St Vincent's Hospital, Sydney (1) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) Australian and New Zealand Urogenital and Prostate Cancer Trials Group (1) Enhanced Emirates Limited (1)
Disease Areas
Prostate Cancer (3)
Get alerts when Testosterone Enanthate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free